Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Pamela Zeitlin to Chloride Channels

This is a "connection" page, showing publications Pamela Zeitlin has written about Chloride Channels.

 
Connection Strength
 
 
 
1.428
 
  1. Schiffhauer ES, Vij N, Kovbasnjuk O, Kang PW, Walker D, Lee S, Zeitlin PL. Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia. Am J Physiol Lung Cell Mol Physiol. 2013 Mar 01; 304(5):L324-31.
    View in: PubMed
    Score: 0.378
  2. Vij N, Zeitlin PL. Regulation of the ClC-2 lung epithelial chloride channel by glycosylation of SP1. Am J Respir Cell Mol Biol. 2006 Jun; 34(6):754-9.
    View in: PubMed
    Score: 0.234
  3. Zeitlin P. Can curcumin cure cystic fibrosis? N Engl J Med. 2004 Aug 05; 351(6):606-8.
    View in: PubMed
    Score: 0.211
  4. Holmes KW, Hales R, Chu S, Maxwell MJ, Mogayzel PJ, Zeitlin PL. Modulation of Sp1 and Sp3 in lung epithelial cells regulates ClC-2 chloride channel expression. Am J Respir Cell Mol Biol. 2003 Oct; 29(4):499-505.
    View in: PubMed
    Score: 0.193
  5. Liang L, MacDonald K, Schwiebert EM, Zeitlin PL, Guggino WB. Spiperone, identified through compound screening, activates calcium-dependent chloride secretion in the airway. Am J Physiol Cell Physiol. 2009 Jan; 296(1):C131-41.
    View in: PubMed
    Score: 0.071
  6. MacDonald KD, McKenzie KR, Henderson MJ, Hawkins CE, Vij N, Zeitlin PL. Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice. Am J Physiol Lung Cell Mol Physiol. 2008 Nov; 295(5):L933-40.
    View in: PubMed
    Score: 0.070
  7. Zeitlin PL. Emerging drug treatments for cystic fibrosis. Expert Opin Emerg Drugs. 2007 May; 12(2):329-36.
    View in: PubMed
    Score: 0.064
  8. Zeitlin PL, Boyle MP, Guggino WB, Molina L. A phase I trial of intranasal Moli1901 for cystic fibrosis. Chest. 2004 Jan; 125(1):143-9.
    View in: PubMed
    Score: 0.051
  9. Zeitlin PL. Emerging drug treatments for cystic fibrosis. Expert Opin Emerg Drugs. 2003 Nov; 8(2):523-35.
    View in: PubMed
    Score: 0.050
  10. Boyle MP, Diener-West M, Milgram L, Knowles M, Foy C, Zeitlin P, Standaert T. A multicenter study of the effect of solution temperature on nasal potential difference measurements. Chest. 2003 Aug; 124(2):482-9.
    View in: PubMed
    Score: 0.049
  11. Edmonds RD, Silva IV, Guggino WB, Butler RB, Zeitlin PL, Blaisdell CJ. ClC-5: ontogeny of an alternative chloride channel in respiratory epithelia. Am J Physiol Lung Cell Mol Physiol. 2002 Mar; 282(3):L501-7.
    View in: PubMed
    Score: 0.044
  12. Uwaifo O, Bamford P, Zeitlin PL, Blaisdell CJ. Acidic pH hyperpolarizes nasal potential difference. Pediatr Pulmonol. 2006 Feb; 41(2):151-7.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)